{"id":"W2107510226","doi":"10.1136/ard.2006.058339","title":"Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"University of Texas Rio Grande Valley","keywords":"Medicine; Psoriatic arthritis; Infliximab; Psoriasis; Dermatology; Internal medicine; Arthritis; Clinical trial; Adalimumab; Etanercept; Physical therapy; Antirheumatic Agents; Rheumatoid arthritis; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002800268,0.0009092963,0.002632549,0.0003359445,0.0005719202,0.001159098,0.000636059,0.001345176,0.001671617],"category_scores_gemma":[0.002936174,0.0003709502,0.001621406,0.000664352,0.0006713988,0.00131438,0.0004042419,0.002515615,0.0003471561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006923912,"about_ca_system_score_gemma":0.0006217939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001367692,"about_ca_topic_score_gemma":0.00240039,"domain_scores_codex":[0.9989063,0.0004982997,0.00008116449,0.0001451236,0.0001241918,0.0002449511],"domain_scores_gemma":[0.9980522,0.0004971744,0.0006214051,0.0002447627,0.0001006911,0.0004837395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8214136,0.01202105,0.0324256,0.0007098592,0.004832155,0.0002739698,0.0004354202,0.001029346,0.007238155,0.0001886305,0.002550615,0.1168816],"study_design_scores_gemma":[0.4417405,0.24007,0.3049161,0.0001624128,0.005272618,0.0006080466,0.0002267312,0.001100623,0.001802717,0.0003677425,0.003620565,0.0001119544],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918202,0.0060251,0.0001305081,0.0003438125,0.00008363719,0.0001142214,0.0003042477,0.00004091905,0.001137448],"genre_scores_gemma":[0.9967231,0.001483351,0.00015637,0.0003691325,0.0001742297,0.00007515856,0.0005015019,0.000009883285,0.000507203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002800268,"threshold_uncertainty_score":0.01480943,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05759758296608489,"score_gpt":0.3530800859068701,"score_spread":0.2954825029407853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}